Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.
Last trade$1.56
Day change-$0.04 (-2.50%)
Day range$1.51 – $1.61
Volume31,361
Market cap$4M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$4.06M
Price / earnings
—
Price / book
6.23×
Price / sales
1,354.92×
EV / sales
1,313.59×
EV / EBITDA
-0.98×
Profitability
Earnings per share
-$1.68
Return on assets
-281.33%
Return on equity
-654.14%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0×
Current ratio
0.77×
Quick ratio
0.77×
Cash ratio
0.14×
Cash flow
Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$2.83M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for TCRT, quarterly periods
Line item
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Q3 FY2024 Sep 30, 2024
Revenue
$0
$0
$3K
$0
$0
$2K
$4K
$0
Cost of revenue
$0
$0
$0
$0
$0
$0
$0
$0
Gross profit
$0
$0
$3K
$0
$0
$2K
$4K
$0
Selling, general and administrative
$564K
$585K
$549K
$718K
$854K
$747K
$845K
$1.01M
Research and development
$388K
$427K
$361K
$469K
$185K
$347K
-$86K
$143K
Total operating expenses
$952K
$1.01M
$910K
$1.19M
$1.04M
$1.09M
$759K
$1.15M
Operating income
-$952K
-$1.01M
-$907K
-$1.19M
-$1.04M
-$1.09M
-$755K
-$1.15M
Interest expense
$0
$0
$0
$0
$0
$0
$0
$0
Income before taxes
-$952K
-$1.01M
-$893K
-$1.16M
-$1.05M
-$1.07M
-$742K
-$1.13M
Income taxes
$0
$0
$0
$0
$0
$0
$0
$0
Net income
-$952K
-$1.01M
-$893K
-$1.16M
-$1.05M
-$1.07M
-$742K
-$1.13M
Net income attributable to common shareholders
-$952K
-$1.16M
-$999K
-$1.16M
-$1.05M
-$1.07M
-$742K
-$1.13M
EBITDA
-$943K
-$1M
-$900K
-$1.19M
-$1.04M
-$1.09M
-$756K
-$1.15M
Basic earnings per share
-$0.41
-$0.59
-$0.43
-$0.55
-$0.63
-$0.67
-$0.46
-$0.70
Diluted earnings per share
-$0.41
-$0.59
-$0.43
-$0.55
-$0.63
-$0.67
-$0.46
-$0.70
Recent news
Company coverage with links to the original publishers.
Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter financial results.
C.H. Robinson Worldwide posted adjusted earnings of 50 cents per share, missing market estimates if 81 cents per share. The company’s quarterly sales came in at $4.20 billion versus estimates of $4.34 billion.
C.H. Robinson Worldwide shares dipped 12.6% to $73.49 on Thursday.
Here are some other stocks moving in today's mid-day session.
Gainers
Minim, Inc. (NASDAQ: MINM) shares climbed 57.3% to $6.45. David E. Lazar recently disclosed a 51% active stake in Minim.
Clearmind Medicine Inc. (NASDAQ: CMND) jumped 51% to $2.17. Clearmind Medicine announced long-term licensing agreement with BIRAD.
NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) climbed 52.9% to $5.00. NeuroBo Pharmaceuticals announced FDA clearance of IND for Phase 1 clinical trial of DA-1726 for the treatment of obesity.
FibroBiologics, Inc. (NASDAQ: FBLG) shares climbed 47.4% to $42.90. FibroBiologics announced direct listing on the NASDAQ.
Celularity Inc. (NASDAQ: CELU) rose 36% to $0.5191. Celularity said it sees FY24 net sales of $50 million to $56 million.
Cimpress plc (NASDAQ: CMPR) jumped 28.8% to $96.90 after the company reported better-than-expected second-quarter financial results and said the board authorized the repurchase of up to $150 million of company shares.
TuSimple Holdings Inc. (NASDAQ: TSP) rose 28% to $0.2950.
Elevai Labs, Inc. (NASDAQ: ELAB) gained 23.5% to $0.84 after gaining 8% on Wednesday.
Asset Entities Inc. (NASDAQ: ASST) climbed 22.8% to $0.5650.
Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) shares jumped 20.4% to $0.6649. Kiora Pharmaceuticals announced a private placement of up to $45 million.
Evaxion Biotech A/S (NASDAQ: EVAX) gained 19.5% to $4.70. Evaxion Biotech announced pricing of $15 million public offering of 3.750 million ADS at $4.00 per ADS.
Nextracker Inc. (NASDAQ: NXT) rose climbed 18.8% to $53.79 after the company reported better-than-expected third-quarter financial results.
SunPower Corporation (NASDAQ: SPWR) jumped 18.1% to $3.5791.
BioRestorative Therapies, Inc. (NASDAQ: BRTX) gained 16.4% to $1.8850.
Corteva, Inc. (NYSE:
Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results.
WD-40 reported quarterly earnings of $1.28 per share which exceeded the analyst consensus estimate of $1.05 per share. The company reported quarterly sales of $140.42 million, clocking in above the Street's estimate of $134.37 million.
WD-40 shares jumped 17.3% to $277.56 on Wednesday.
Here are some other stocks moving in today's mid-day session.
Gainers
Nauticus Robotics, Inc. (NASDAQ: KITT) climbed 87.8% to $0.5501. Nauticus Robotics secured additional funding and appointed John W. Gibson, Jr as interim CEO.
Clearmind Medicine Inc. (NASDAQ: CMND) shares jumped 47.7% to $3.0570. Clearmind Medicine completed a Type A Meeting with the FDA for clinical trial of its proprietary MEAI-based, CMND-100 compound, for the treatment of alcohol use disorder.
Sana Biotechnology, Inc. (NASDAQ: SANA) gained 46.8% to $7.57. Sana Biotechnology recently announced FDA clearance of investigational new drug application for SC262.
Ucommune International Ltd (NASDAQ: UK) jumped 37.8% to $4.98.
Vicarious Surgical Inc. (NASDAQ: RBOT) rose 37% to $0.6851.
Nvni Group Limited (NASDAQ: NVNI) climbed 35.2% to $2.6091.
EchoStar Corporation (NASDAQ: SATS) gained 31% to $16.50. EchoStar completed merger with DISH Network Corporation.
Amarin Corporation plc (NASDAQ: AMRN) climbed 28.8% to $1.25 after the company reported strong preliminary FY23 total revenues.
Exicure, Inc. (NASDAQ: XCUR) shares rose 17% to $0.5501. Exicure was granted broad U.S. patent #11866700 for "Liposomal Nucleic Acid Constructs Presenting Antisense Oligonucleotides For Knockdown Of Interleukin ...
Shares of Dermata Therapeutics, Inc. (NASDAQ: DRMA) rose sharply in pre-market trading after the company announced the issuance of a new patent in Japan for its DMT410 program for the treatment of hyperhidrosis.
Dermata Therapeutics shares jumped 57.3% to $0.9601 in pre-market trading.
Here are some other stocks moving in pre-market trading.
Gainers
Ainos, Inc.(NASDAQ: AIMD) gained 142.6% to $4.20 in pre-market trading after falling more than 12% on Thursday.
Safe and Green Development Corporation (NASDAQ: SGD) shares rose 34.5% to $1.83 in pre-market trading. Safe And Green Development recently issued an update on LOI for acquisition of Xene AI Software platform.
Pinstripes Holdings Inc. (NYSE: PNST) shares gained 17.4% to $6.18 in pre-market trading after dipping over 35% on Thursday.
Fusion Pharmaceuticals Inc. (NASDAQ: FUSN) shares climbed 12.6% to $9.50 in pre-market trading. Fusion Pharmaceuticals said it has achieved alignment with the FDA on a protocol and development plan for FPI-2265.
Inhibikase Therapeutics, Inc. (NASDAQ: IKT) shares gained 10.5% to $1.48 in pre-market trading.
Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares rose ...
Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy program.
Compugen shares jumped 204.1% to $2.22 on Tuesday.
Here are some other stocks moving in today's mid-day session.
Gainers
Intelligent Bio Solutions Inc. (NASDAQ: INBS) gained 73% to $0.4853. Intelligent Bio Solutions received National Association of Testing Authorities accreditation for its Intelligent Fingerprinting Drug Screening Solution.
Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares surged 64% to $1.6601. Panbela Therapeutics shares jumped 120% on Monday after US WorldMeds received FDA approval of eflornithine.
Jin Medical International Ltd.(NASDAQ: ZJYL) climbed 49.2% to $151.96 after jumping around 264% on Monday.
ProSomnus, Inc. (NASDAQ: OSA) gained 27.6% to $0.8017. ProSomnus announced data published by Cureus Journal of Medical Science showed successful treatment of obstructive sleep apnea with prosomnus precision oral appliance devices.
Infobird Co., Ltd (NASDAQ: IFBD) shares gained 27.4% to $1.7266 after the company inked a new business cooperation in software development of information technology system.
MIND Technology, Inc. (NASDAQ: MIND) rose 23.1% to $5.86.
Yoshiharu Global Co. (NASDAQ: YOSH) rose 21.1% to $6.20.
Optex Systems Holdings, Inc (NASDAQ: OPXS) gained 18.2% to $4.86.
Sunnova Energy International Inc. (NASDAQ: NOVA) jumped 16.3% to $15.32. Piper Sandler upgraded Sunnova Energy Intl from Neutral to Overweight and raised the price target from $13 to $26.
Cipher Mining Inc. (NASDAQ: CIFR) rose 16% to $3.6450.
LogicMark, Inc. (NASDAQ:
Shares of Motus GI Holdings, Inc. (NASDAQ: MOTS) shares fell sharply in pre-market trading after the company priced its $5 million public offering.
Motus GI Holdings shares dipped 46.5% to $1.15 in pre-market trading.
Here are some other stocks moving in pre-market trading.
Gainers
Infobird Co., Ltd (NASDAQ: IFBD) shares rose 128.8% to $3.10 in pre-market trading after the company inked a new business cooperation in software development of information technology system.
Jin Medical International Ltd.(NASDAQ: ZJYL) gained 76.7% to $179.96 in pre-market trading after jumping around 264% on Monday.
SOBR Safe, Inc. (NASDAQ: SOBR) shares climbed 33.7% to $0.6250 in pre-market trading after declining around 7% on Monday.
EG Acquisition Corp. (NYSE: EGGF) shares gained 33.2% to $14.38 in pre-market trading.
Nxu, Inc. (NASDAQ: NXU) shares rose 31% to $0.0258 in pre-market trading. Nxu announced that Nasdaq approved company's request for continued listing, subject to Nxu demonstrating compliance with the listing rules on or before April 7, 2024.
Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares surged 29.7% ...
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.